After 60 years at the location, BD (Becton, Dickinson and Company) is winding down operations at a plant in Drogheda, Ireland where oncology, interventional radiology and critical care products are manufactured.

The move, which is expected to play out over two and-a-half years, will result in the loss of about 200 jobs, according to local news outlet RTE.

The decision is part of the company's 2025 strategy, which includes efforts to simplify the company through optimizing its manufacturing network, right-sizing inventory and production and simplifying business processes.

Neil McGowan, manufacturing divisional organizer with SIPTU, an Irish trade union, said the first round of redundancies involving around 110 workers would commence in March 2025, with the remaining redundancies between then and September 2026, RTE reported.

BD has three other locations in Ireland and employs around 1,000 people across all four.

The company said it remains committed to Ireland and that there will be no impact on any of BD's other Irish sites as a result of the decision.

In June, the company acquired Edwards Lifesciences' Critical Care product group for $4.2 billion in an effort to enhance its portfolio of smart connected care solutions and expand its advanced monitoring technology capabilities.

European News Homepage